| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.LUNGCAN.2011.11.012 |
| P698 | PubMed publication ID | 22153832 |
| P2093 | author name string | M Grunnet | |
| J B Sorensen | |||
| P433 | issue | 2 | |
| P921 | main subject | lung cancer | Q47912 |
| P304 | page(s) | 138-143 | |
| P577 | publication date | 2011-12-06 | |
| P1433 | published in | Lung Cancer | Q641464 |
| P1476 | title | Carcinoembryonic antigen (CEA) as tumor marker in lung cancer | |
| P478 | volume | 76 |
| Q37247888 | A SPR biosensor based on signal amplification using antibody-QD conjugates for quantitative determination of multiple tumor markers |
| Q92618068 | A combination of tumor and molecular markers predicts a poor prognosis in lung adenocarcinoma |
| Q64983897 | A meta-analysis and bioinformatics exploration of the diagnostic value and molecular mechanism of miR-193a-5p in lung cancer. |
| Q33827932 | A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer |
| Q36375034 | ALX1 promotes migration and invasion of lung cancer cells through increasing snail expression |
| Q37618865 | Aberrant glycosylation as biomarker for cancer: focus on CD43. |
| Q38931288 | Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer |
| Q34149036 | Adenoviral targeting using genetically incorporated camelid single variable domains |
| Q38754498 | Adoptive T-Cell Therapy for Solid Tumors |
| Q37708022 | Advances in epigenetic biomarker research in colorectal cancer |
| Q42023221 | An ALK translocation positive carcinoma of the lung presenting as uremia due to bilateral renal obstruction |
| Q104073710 | An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression |
| Q90152104 | Analysis of Segmental Lymph Node Metastasis and Clinical Features in cT1N0M0 Lung Adenocarcinoma |
| Q89804827 | Applications of Graphene Quantum Dots in Biomedical Sensors |
| Q90480392 | Aquaporin 5 promotes tumor migration and angiogenesis in non-small cell lung cancer cell line H1299 |
| Q89602661 | Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression |
| Q38364462 | Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs |
| Q29248731 | Biosensors Incorporating Bimetallic Nanoparticles |
| Q55066534 | CEA serum level as early predictive marker of outcome during EGFR-TKI therapy in advanced NSCLC patients. |
| Q47558061 | CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer |
| Q36515785 | Cancer treatment using peptides: current therapies and future prospects |
| Q47109220 | Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers |
| Q38113267 | Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promise. |
| Q90685805 | Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 72-4 in Gastric Cancer: Is the Old Band Still Playing? |
| Q36358540 | Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma |
| Q91631004 | Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer |
| Q39034684 | Challenges and opportunities for monoclonal antibody therapy in veterinary oncology. |
| Q36253580 | Chronic nasal exposure to nanoparticulate TiO2 causes pulmonary tumorigenesis in male mice |
| Q61816599 | Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients |
| Q33595133 | Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer |
| Q64945266 | Clinical application of plasma mitochondrial DNA content in patients with lung cancer. |
| Q35943122 | Collecting Protein Biomarkers in Breath Using Electret Filters: A Preliminary Method on New Technical Model and Human Study |
| Q89562510 | Comments on the Measurement of Lung Cancer Tumor Markers in Workers of a Glass Wool Company |
| Q53155763 | Comparison of LUMIPULSE(®) G1200 With Kryptor and Modular E170 for the Measurement of Seven Tumor Markers. |
| Q98386431 | Comparison of the diagnostic value of CEA combined with OPN or DKK1 in non-small cell lung cancer |
| Q47130839 | Current and Prospective Protein Biomarkers of Lung Cancer. |
| Q47135084 | DNA Methylation Analysis of the SHOX2 and RASSF1A Panel in Bronchoalveolar Lavage Fluid for Lung Cancer Diagnosis |
| Q34335597 | Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules |
| Q41902053 | Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer |
| Q42720974 | Detection of cancer embryo antigen and endothelin-1 in exhaled breath condensate: A novel approach to investigate non-small cell lung cancer |
| Q58129336 | Determination of Liver Cancer Biomarkers by Surface-Enhanced Raman Scattering Using Gold-Silica Nanoparticles |
| Q36439356 | Development and validation of clinical diagnostic models for the probability of malignancy in solitary pulmonary nodules. |
| Q38061969 | Development of antibody therapeutics for small cell lung cancer |
| Q49628399 | Diagnostic accuracy of MALDI-TOF mass spectrometry for non-small cell lung cancer: a meta-analysis |
| Q41908975 | Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis. |
| Q64916693 | Diagnostic efficacy of broncho-alveolar lavage carcino-embronic antigen in carcinoma of lung. |
| Q35959035 | Diagnostic value of CYFRA 21-1 and CEA for predicting lymph node metastasis in operable lung cancer |
| Q36046608 | Diagnostic value of Cyfra21-1, SCC and CEA for differentiation of early-stage NSCLC from benign lung disease |
| Q36408318 | Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma |
| Q36651307 | Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma |
| Q64988391 | Effects of epidural analgesia on cancer recurrence and long-term mortality in patients after non-small-cell lung cancer resection: a propensity score-matched study. |
| Q99610684 | Elevated carcinoembryonic antigen and bronchial obstruction caused by a rotten vegetable leaf mimic lung cancer: A case report |
| Q49712352 | Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report |
| Q38778137 | Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer |
| Q47158629 | EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner |
| Q88599780 | Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer |
| Q47139923 | Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients |
| Q61451669 | Expression of p53 in ground-glass nodule of lung cancer and non-lung cancer patients |
| Q35065394 | Expression of two basic mRNA biomarkers in peripheral blood of patients with non-small cell lung cancer detected by real-time rt-PCR, individually and simultaneously. |
| Q35686754 | Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue |
| Q90131524 | Gold/WS2 nanocomposites fabricated by in-situ ultrasonication and assembling for photoelectrochemical immunosensing of carcinoembryonic antigen |
| Q92257991 | Graphene Quantum Dot-Based Electrochemical Immunosensors for Biomedical Applications |
| Q47206943 | HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study |
| Q38947077 | History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer |
| Q49319563 | Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non-Small Cell Lung Cancer |
| Q51562958 | Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. |
| Q58591218 | Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible? |
| Q41513953 | Impact of smoking on outcome of resected lung adenocarcinoma |
| Q49228740 | Improving biosensing activity to carcinoembryonic antigen with orientated single domain antibodies |
| Q64965758 | Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1). |
| Q55512954 | Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA). |
| Q37702624 | LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle |
| Q49404537 | Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report |
| Q49831684 | Loss of Muscle Mass is a Novel Predictor of Postoperative Early Recurrence in N2-Positive Non-Small-Cell Lung Cancer |
| Q64235247 | Lymph node metastasis in Chinese patients with clinical T1 non-small cell lung cancer: A multicenter real-world observational study |
| Q50107843 | Measurement of Lung Cancer Tumor Markers in a Glass Wool Company Workers Exposed to Respirable Synthetic Vitreous Fiber and Dust. |
| Q33761760 | Mechanism of modulation through PI3K-AKT pathway about Nepeta cataria L.'s extract in non-small cell lung cancer |
| Q38869738 | Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications. |
| Q91639535 | Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer |
| Q89489914 | MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways |
| Q47137585 | Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma |
| Q61811249 | Neuron-Specific Enolase Is an Independent Prognostic Factor in Resected Lung Adenocarcinoma Patients with Anaplastic Lymphoma Kinase Gene Rearrangements |
| Q97539178 | Noninvasive biomarkers for lung cancer diagnosis, where do we stand? |
| Q38701486 | Oligonucleotide-based biosensors for in vitro diagnostics and environmental hazard detection |
| Q35104929 | Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer |
| Q37386375 | Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan |
| Q59809159 | Potential clinical application of lncRNAs in non-small cell lung cancer |
| Q92996310 | Potential early clinical stage colorectal cancer diagnosis using a proteomics blood test panel |
| Q37662137 | Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma |
| Q37295811 | Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer |
| Q64106056 | Predictive factors for long-term responders of pemetrexed maintenance treatment in non-small cell lung cancer |
| Q91750120 | Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma |
| Q54378597 | Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancer. |
| Q64117635 | ProGRP as early predictive marker of non-small-cell lung cancer to small-cell lung cancer transformation after EGFR-TKI treatment |
| Q41461528 | Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer |
| Q64933106 | Prognostic Value of Serum Tumor Markers in Patients With Stage III NSCLC Treated With Chemoradiotherapy. |
| Q35200656 | Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers |
| Q53323484 | Prognostic impact of cytological fluid tumor markers in non-small cell lung cancer. |
| Q37672230 | Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer |
| Q42688261 | Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer - significance and development. |
| Q35532904 | Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis |
| Q37007121 | Prognostic value of tumor markers, NSE, CA125 and SCC, in operable NSCLC Patients |
| Q36664240 | Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein |
| Q47220323 | Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study |
| Q47182062 | Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A monocentric population-based analysis |
| Q47579713 | Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer |
| Q49733370 | Screening of FOXD3 targets in lung cancer via bioinformatics analysis |
| Q64245332 | Sensors for Lung Cancer Diagnosis |
| Q33829604 | Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer |
| Q36793155 | Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma |
| Q59812795 | Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia |
| Q51570919 | Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis. |
| Q58797016 | Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer |
| Q37157669 | Serum Tumor Marker Use in Patients With Advanced Solid Tumors |
| Q33573132 | Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer |
| Q40839790 | Serum carbohydrate antigen 12-5 level enhances the prognostic value in primary adenosquamous carcinoma of the lung: a two-institutional experience |
| Q92088333 | Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer |
| Q36149181 | Simultaneous Quantification of Serum Nonesterified and Esterified Fatty Acids as Potential Biomarkers to Differentiate Benign Lung Diseases from Lung Cancer |
| Q47134535 | Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer |
| Q90242656 | Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer |
| Q38757865 | Surgical margins in the veterinary cancer patient |
| Q58128022 | Synthesis and Characterization of Silver Nanoparticle Modified 3-Aminophenol Resin Microspheres with Application for Determination of Carcinoembryonic Antigens by Surface-Enhanced Raman Scattering |
| Q38715439 | The Preoperative Composite Physiologic Index May Predict Mortality in Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema |
| Q33735551 | The Roles of Carcinoembryonic Antigen in Liver Metastasis and Therapeutic Approaches |
| Q36211371 | The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma |
| Q64062553 | The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer |
| Q27027383 | The diagnostic accuracy of HE4 in lung cancer: a meta-analysis |
| Q51605230 | The diagnostic value of tumor markers in bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma. |
| Q92107853 | The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers |
| Q36268128 | The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients |
| Q41093297 | The relationship between tumor markers and pulmonary embolism in lung cancer |
| Q91940334 | Therapy of 125I particles implantation inhibited the local growth of advanced non-small cell lung cancer: a retrospective clinical study |
| Q64106986 | Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study |
| Q92876924 | Three Markers in Cancerous and Healthy Cells of Patients with Non-Small-Cell Lung Carcinoma (NSCLC) |
| Q33932016 | Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection |
| Q38725552 | Tumour-associated antigens and their anti-cancer applications |
| Q64928639 | Two Cases of Transiently Elevated Serum CEA Levels in Severe Hypothyroidism without Goiter. |
| Q50072119 | Utility of Multiple Increased Lung Cancer Tumor Markers in Treatment of Patients with Advanced Lung Adenocarcinoma |
Search more.